e 5324 has been researched along with cholestyramine resin in 1 studies
| Studies (e 5324) | Trials (e 5324) | Recent Studies (post-2010) (e 5324) | Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 2,669 | 342 | 190 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimori, T; Hayashi, K; Hiyoshi, H; Kimura, T; Kobayashi, H; Kogushi, M; Ohtsuka, I; Saeki, T; Tanaka, H; Yamada, T | 1 |
1 other study(ies) available for e 5324 and cholestyramine resin
| Article | Year |
|---|---|
Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits.
Topics: Anilides; Animals; Aorta, Thoracic; Arteriosclerosis; Cholestyramine Resin; Dose-Response Relationship, Drug; Lipid Metabolism; Liver; Male; Phenylurea Compounds; Probucol; Rabbits; Sterol O-Acyltransferase; Tunica Intima; Tunica Media | 1994 |